Pavmed Inc. is a diversified commercial-stage medical technology company focused on developing, acquiring, and commercializing products across medical devices, diagnostics, and digital health. The company’s portfolio addresses unmet clinical needs in areas such as gastrointestinal endoscopy, cancer detection, remote patient monitoring, vascular access, and other minimally invasive care settings. Through its operating subsidiaries, Pavmed supports products and platforms designed for use by healthcare providers, hospitals, and patients, with an emphasis on improving workflow, diagnosis, and care delivery. Its current business is centered on bringing novel healthcare technologies into commercial use and expanding access to tools that support prevention, treatment, and ongoing patient management.
Website360 Madison Avenue
New York, NY, 10017
United States
Motley Fool Press Release.
Moby summary of PAVmed Inc.'s Q2 2026 earnings call
Investors talking about PAVM also mention
What share of all stock conversation is about PAVM?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Attention | 0% 0 | 0% +0 | 0% 0 | 0% 0 |
Of the messages about PAVM that take a side, what share is each?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Bullish | 0% | 0% | 0% | 75.96% +2.59 | ||
| Bearish | 100% | 100% | 100% | 24.04% -2.59 |
Of the messages about PAVM that carry a topic, what share is each?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Announcements | — | — | 100% | 34.83% | ||
| Analysts | — | — | 0% | 9.89% | ||
| Macro | — | — | 0% | 23.33% | ||
| Technical Analysis | — | — | 0% | 31.03% | ||
| Controversies | — | — | 0% | 0.69% | ||
| Earnings | — | — | 0% | 0.23% |
Of the messages about PAVM, what share comes from each group?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Regulars | 100% | 100% | 83.33% | 20.82% | ||
| Newcomers | 0% | 0% | 16.67% | 79.18% |